Selected Publication:
Fereberger, W; Leb, G; Goebel, R; Samonigg, H; Robier, FP.
The current status of scintigraphy in oncology (author's transl)
ACTA MED AUST. 1981; 8(3): 88-92.
Web of Science
PubMed
- Co-authors Med Uni Graz
-
Samonigg Hellmut
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Abstract:
- The clinical usefulness of tumor scanning methods is discussed under the practical considerations of tumor screening, determination of tumor size and noninvasive tumor staging as well as diagnostic follow-up after therapy. Scintigraphy as a primary diagnostic tool is mainly restricted to suspicious enlargements of the thyroid gland whereas scintigraphy with 67Ga-citrate in Hodgkin's disease and bone scintigraphy with 99mTc-phosphates in tumors with tendencies to early bone metastases are widely used non-invasive diagnostic means for the evaluation of tumor propagation. Post therapy conversion of positive findings is of less predictive value than than persistence of a positive scan. Some results of the literature are discussed with our own experiences.
- Find related publications in this database (using NLM MeSH Indexing)
-
Antineoplastic Agents - therapeutic use
-
Diagnosis, Differential - therapeutic use
-
Humans - therapeutic use
-
Neoplasm Metastasis - therapeutic use
-
Neoplasms - radionuclide imaging